1-18 of 18
Keywords: Policy
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Public Health Genomics (2019) 22 (3-4): 140–144.
Published Online: 24 September 2019
..., and inherited predisposition to colorectal cancer [ 8 ]. In addition, population-based sequencing for cancer susceptibility [ 9 ], reproductive carrier screening [ 7 ], and the diseases of ageing [ 10 ] are being investigated in research cohorts. These efforts are informing genomic health policy in Australia...
Journal Articles
Public Health Genomics (2017) 20 (4): 247–256.
Published Online: 26 October 2017
... to disclose all results from any genetic test. Insurers can then use this information to adjust premiums and make policy decisions. The Australian Financial Services Council (FSC; an industry body) developed and maintains the relevant industry standard, which was updated in late 2016. Aims/Objective...
Journal Articles
Public Health Genomics (2017) 19 (6): 352–363.
Published Online: 05 January 2017
... on the EU countries. Particular attention is paid to issues pertaining to pricing and reimbursement policies, the availability of essential genomic tests which differs between various countries owing to differences in disease prevalence and public health relevance, the prescribing and use of genomic testing...
Journal Articles
Journal Articles
Public Health Genomics (2015) 18 (6): 349–358.
Published Online: 11 November 2015
... to be therapeutically useful, but few become part of the clinical decision-making process due to technical, validation and market access issues. To reduce this attrition rate, there is a significant need for policy makers and reimbursement agencies to define specific evidence requirements for the introduction...
Journal Articles
Public Health Genomics (2014) 17 (3): 149–157.
Published Online: 28 March 2014
... or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Biobank Data sharing Epidemiological research Ethics Law Policy Statistical analysis...
Journal Articles
Journal Articles
Public Health Genomics (2012) 15 (5): 272–284.
Published Online: 20 June 2012
... Data sharing Focus groups Genetic privacy Policy Public engagement Qualitative research Reciprocity Research participation When participants are recruited into a biobank study, they typically donate samples such as of blood, urine, saliva, and tissue. These donations are different from...
Journal Articles
Public Health Genomics (2012) 15 (2): 92–97.
Published Online: 20 December 2011
...D. Duquette; K. Lewis; J. McLosky; J. Bach Objective: The Michigan Department of Community Health (MDCH) Cancer Genomics Program sought to increase the number of health plans with a written policy aligned with the United States Preventive Services Task Force (USPSTF) Grade B Recommendation stating...
Journal Articles
Public Health Genomics (2010) 13 (4): 197–206.
Published Online: 15 April 2010
... build on previous work that has addressed the former point and focus primarily on the latter. We argue that one way to increase the likelihood of results of public engagement being taken up in policy is through framing the issues that are deliberated by members of the public based in part...
Journal Articles
Public Health Genomics (2011) 14 (2): 96–103.
Published Online: 15 April 2010
... and only about half indicated to have a policy for cross-border sharing of samples. Yet, scientific collaborations based on the use of each biobank appear to be prominent. Significant variability was found in terms of consent requirements and related procedures as well as for privacy and data protection...
Journal Articles
Public Health Genomics (2010) 13 (6): 368–377.
Published Online: 15 January 2010
... identified in the focus group data: (a) a wide spectrum of understanding of genetic research; (b) pros and cons of participation in genetic research; (c) influence of credibility and trust of the research institution; (d) concerns about sharing genetic research data and need for transparency in the Policy...
Journal Articles
Public Health Genomics (2009) 13 (2): 95–105.
Published Online: 29 June 2009
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Clinical genetics Genetic testing Policy Registry National Institutes of Health (NIH) 10.13039/100000002...
Journal Articles
Public Health Genomics (2009) 12 (3): 180–184.
Published Online: 10 February 2009
... will be challenged to adapt to the disruptions that will arise as our health care system seeks to embrace those technologies. This paper identifies many of the key issues and stakeholders to be directly effected, including payers, providers, and suppliers. An even greater challenge faces public policy makers...
Journal Articles
Public Health Genomics (2009) 12 (3): 134–141.
Published Online: 10 February 2009
... in the development and licensing of PGx diagnostic tests for improving the safety and efficacy of out-of-patent drugs. It therefore seems that one key aspect where policy can affect the clinical uptake of PGx is via sustaining large-scale industry-academia collaborations for developing and proving the utility of PGx...
Journal Articles
Journal Articles
Public Health Genomics (2008) 12 (2): 121–128.
Published Online: 02 October 2008
... and to identify pregnancies at risk of chromosomal and neural tube defects, while carrier screening programs are essentially ad hoc. Despite inevitable tensions between federal and state policies, there is increasing evidence of the development of national policy in a range of genetic issues, not least in newborn...